Enzyme Replacement Therapy and MPS I Treatment: Transforming Care for Rare Genetic Disease Therapy
Rare genetic diseases present unique challenges for healthcare systems, requiring specialized knowledge, innovative therapies, and comprehensive care approaches. Hurler Syndrome, the most severe form of Mucopolysaccharidosis type I, exemplifies these challenges and the remarkable progress being made in enzyme replacement therapy. The Hurler Syndrome treatment market is experiencing...
0 Comments 0 Shares 141 Views 0 Reviews